Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The tumor suppressor protein p53 plays a critical role in preventing cancer by inducing apoptosis.
• Translationally Controlled Tumor Protein (TCTP) is implicated in various cellular processes, including cell proliferation and survival.

Purpose of the Study:

• To identify novel proteins interacting with TCTP.
• To investigate the functional consequences of the TCTP-p53 interaction in lung cancer.
• To determine TCTP's role in regulating apoptosis and p53 stability.

Main Methods:

• Yeast two-hybrid screening was employed to identify TCTP-interacting proteins.
• Site-directed mutagenesis was used to map critical binding sites between TCTP and p53.
• Overexpression and small interfering RNA (siRNA) systems were developed to modulate TCTP and p53 levels in lung carcinoma cells.

Main Results:

• p53 was identified as a novel TCTP-interacting protein.
• TCTP overexpression in lung carcinoma cells inhibited p53-mediated apoptosis.
• Inhibition of TCTP expression using siRNA enhanced apoptosis in lung carcinoma cells.
• TCTP overexpression was found to promote the degradation of p53.
• The interaction between TCTP and p53 was shown to prevent apoptosis by destabilizing p53.

Conclusions:

• TCTP interacts with p53 and negatively regulates apoptosis in lung cancer.
• TCTP destabilizes p53, thereby inhibiting p53-mediated cell death.
• Targeting the TCTP-p53 interaction may represent a therapeutic strategy for lung cancer.